Healthcare Data Analytics companies secured $1.5 billion in venture capital funding from 33 funding rounds in the first half (1H) of 2021, approximately a 90% increase year-over-year, compared to $826 million raised in 35 funding rounds in 1H 2020, according to the recently released Mercom Digital Health Funding and M&A Report.
The top eight healthcare data analytics companies secured 70% ($1.05 billion) of the total $1.5 billion funding during 1H 2021.
Top funded analytics companies in 1H 2021:
Komodo Health, an AI-enabled data analytics software platform for healthcare providers, announced a $220 million Series E funding round led by Tiger Global Management and joined by Casdin Capital, with participation from existing investors. Including the latest funding round, Komodo Health has raised over $300 million to date.
Evidation Health, a health data analytics company, announced the close of $153 million in a Series E growth funding round. The round was co-led by OMERS Growth Equity and Kaiser Permanente Group Trust with participation from existing investors. Including the latest funding round, Evidation Health has raised over $250 million to date.
Axtria, an AI-enabled healthcare data analytics platform, received a $150 million growth investment from Bain Capital Tech Opportunities.
Clarify Health, a predictive healthcare data analytics solution, raised $115 million in Series C funding. Insight Partners led the round with Spark Capital, Concord Health Partners, HWVP, KKR, Rivas Capital, and Sigmas Group. Including the latest funding round, Clarify Health has raised over $200 million to date.
Aetion, a provider of evidence-based analytics solutions for payers, biopharma, and medical device customers, announced a $110 million Series C funding round. The round was led by Warburg Pincus, with additional investments from B Capital and Foresite Capital, and others.
Innovaccer, a healthcare data startup, raised $105 million in a Series D round. The round values the company at $1.3 billion. Tiger Global Management led the funding round with participation from existing investors, including M12 (Microsoft’s Venture Fund) and new investor OMERS Growth Equity. Including the latest round, Innovaccer has raised $225 million to date.
Personal Genome Diagnostics (PGDx), a provider of cancer genome testing analysis products for laboratories, raised $103 million in Series C financing led by Cowen Healthcare Investments with participation from other investors.
Caresyntax, a surgical data analytics company, closed a $100 million Series C funding round. PFM Health Sciences led the funding round with Optum Ventures, Intel Capital, Lauxera Capital Partners, Vesalius Biocapital III, Arno Capital, Rezayat Investments, IPF Partners, Relyens Group, and Surgical.AI.
Digital Health data analytics companies have raised $10 billion since 2010, according to Mercom’s digital health funding data.
Image Credit: Diameter Health
